DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST)
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Daiichi Sankyo
Related studies linked through entity extraction aliases.
HER2-PREDICT: Translational Study of Tumor Samples From Patients Treated With Trastuzumab Deruxtecan (T-DXd; DS-8201a)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
IMPROVE Stroke Care- Developing and Optimizing Regional Systems of Stroke Care
- Status
- COMPLETED
- Phase
- N/A
Study of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy Participants
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Rotterdam EDOXaban Leaflet Evaluation in Patients After Transcatheter Aortic Valve Implantation
- Status
- UNKNOWN
- Phase
- PHASE3
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
- Status
- RECRUITING
- Phase
- N/A
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Trial to Compare Efficacy and Safety of Chemotherapy/Quizartinib vs Chemotherapy/Placebo in Adults FMS-like Tyrosine Kinase 3 (FLT3) Wild-type Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Real-life Clinical Outcomes of Direct Oral Anticoagulants (MACACOD)
- Status
- RECRUITING
- Phase
- N/A
Baseline Epidemiologic Assessment of Abuse-Deterrence of MorphaBond Extended Release (BEAD-MB)
- Status
- COMPLETED
- Phase
- N/A
The Effect of CS-3150 Exposure on Corrected QT (QTc) Interval Duration in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
DS-8201a in HER2-positive Gastric Cancer That Cannot Be Surgically Removed or Has Spread (DESTINY-Gastric02)
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Low-Fat Food on Pexidartinib Pharmacokinetics in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Metastatic Breast Cancer in Austria
- Status
- RECRUITING
- Phase
- N/A
Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC)
- Status
- RECRUITING
- Phase
- N/A
Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Expanded Treatment Protocol for Adults With FLT3-ITD Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) to Receive Quizartinib
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3